silence therapeutics plc
(SLN:London Stock Exchange)
Tim Freeborn B.A., A.C.A.
Finance Director, Company Secretary and Director, Silence Therapeutics plc
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Timothy Freeborn, also known as Tim, B.A., A.C.A, serves as a Company Secretary of Silence Therapeutics Plc and has been its Finance Director since October 2012. Mr. Freeborn served as the Head of Research at XCAP Securities plc, Research Division. He served as Equity Analyst at Evolution Securities Ltd., Research Division. Mr. Freeborn serves as a Director of Silence Therapeutics Plc.
1 Lyric SquarePhone: 44 20 3700 9711
London, Greater London W6 0NB
Board Members Memberships*
Finance Director, Company Secretary and Director
Education*There is no Education data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|J. Michael French||Chairman, Chief Executive Officer and President|
Marina Biotech, Inc.
|John M. Maraganore M.D., Ph.D.||Chief Executive Officer and Executive Director|
Alnylam Pharmaceuticals, Inc.
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|$580.0K||Compensation as of Fiscal Year 2014.|